Skip to main content

and
  1. No Access

    Article

    Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia

    Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal prognosis and further thera...

    Corina Schneidawind, Volker Hagmaier, Christoph Faul, Lothar Kanz in Annals of Hematology (2018)